15.80

0.19% -0.03

After Hours: 16.21 0.41 +2.59%

ZimVie Inc (ZIMV)

Overview News Price History Option Chain Financials Discussions Forecast

ZimVie Inc stock is currently priced at $15.80, with a 24-hour trading volume of 143.80K. It has seen a -0.19% decreased in the last 24 hours and a -9.20% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $15.69 pivot point. If it approaches the $15.99 resistance level, significant changes may occur.

Previous Close:

$15.83

Open:

$16.21

24h Volume:

143.80K

Market Cap:

$430.09M

Revenue:

$457.43M

Net Income/Loss:

$-393.28M

P/E Ratio:

-4.6746

EPS:

-3.38

Net Cash Flow:

$24.66M

1W Performance:

-0.13%

1M Performance:

-9.20%

6M Performance:

+100.51%

1Y Performance:

+104.93%

1D Range:

$15.74

$16.23

52W Range:

$6.52

$20.91

ZimVie Inc Stock (ZIMV) Company Profile

Name

ZimVie Inc

Sector

Healthcare (1221)

Industry

Medical Devices (160)

Phone

303 443 7500

Address

10225 Westmoor Drive, Westminster

Employee

2,700

Twitter

Next Earnings Date

2024-05-15

Latest SEC Filings

ZIMV's Discussions on Twitter

ZimVie Inc Stock (ZIMV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-21-22	Initiated	Barclays	Underweight
Jun-17-22	Initiated	JP Morgan	Neutral
Mar-18-22	Initiated	Guggenheim	Neutral

ZimVie Inc Stock (ZIMV) Latest News

ZimVie to Report First Quarter Financial Results on May 8, 2024

GlobeNewswire Inc.

Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday

Benzinga

ZimVie Announces Closing of Sale of Spine Business

GlobeNewswire Inc.

ZimVie (ZIMV) Q4 2023 Earnings Call Transcript

The Motley Fool

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

GlobeNewswire Inc.

ZimVie Announces Launch of Next-Generation TSX® Implant in Japan

GlobeNewswire Inc.

ZimVie Inc Stock (ZIMV) Financials Data

ZimVie Inc (ZIMV) Revenue 2024

ZIMV reported a revenue (TTM) of $457.43 million for the quarter ending December 31, 2023, a -1.26% decline year-over-year.

ZimVie Inc (ZIMV) Net Income 2024

ZIMV net income (TTM) was -$393.28 million for the quarter ending December 31, 2023, a -515.65% decrease year-over-year.

ZimVie Inc (ZIMV) Cash Flow 2024

ZIMV recorded a free cash flow (TTM) of $24.66 million for the quarter ending December 31, 2023, a +1,386% increase year-over-year.

ZimVie Inc (ZIMV) Earnings per Share 2024

ZIMV earnings per share (TTM) was -$14.88 for the quarter ending December 31, 2023, a -508.86% decline year-over-year.

ZimVie Inc., a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; hardware and software solutions consist of intraoral scanners and RealGUIDE; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.